首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   252114篇
  免费   17859篇
  国内免费   1130篇
耳鼻咽喉   2789篇
儿科学   6499篇
妇产科学   4600篇
基础医学   32951篇
口腔科学   4561篇
临床医学   25329篇
内科学   53624篇
皮肤病学   3394篇
神经病学   24307篇
特种医学   8403篇
外国民族医学   11篇
外科学   38455篇
综合类   3458篇
一般理论   318篇
预防医学   21402篇
眼科学   6561篇
药学   16975篇
  6篇
中国医学   361篇
肿瘤学   17099篇
  2023年   1340篇
  2022年   2411篇
  2021年   5441篇
  2020年   3264篇
  2019年   5302篇
  2018年   5952篇
  2017年   4473篇
  2016年   4961篇
  2015年   5831篇
  2014年   8611篇
  2013年   11801篇
  2012年   18019篇
  2011年   18902篇
  2010年   10576篇
  2009年   9426篇
  2008年   16599篇
  2007年   17452篇
  2006年   17305篇
  2005年   17281篇
  2004年   16191篇
  2003年   15044篇
  2002年   14056篇
  2001年   2106篇
  2000年   1598篇
  1999年   2318篇
  1998年   3066篇
  1997年   2561篇
  1996年   2185篇
  1995年   2097篇
  1994年   1746篇
  1993年   1574篇
  1992年   1261篇
  1991年   1153篇
  1990年   1001篇
  1989年   973篇
  1988年   970篇
  1987年   948篇
  1986年   952篇
  1985年   964篇
  1984年   1220篇
  1983年   1123篇
  1982年   1364篇
  1981年   1313篇
  1980年   1145篇
  1979年   706篇
  1978年   747篇
  1977年   635篇
  1976年   584篇
  1975年   469篇
  1974年   472篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
Microvascular thrombosis is a prominent feature in cardiac delayed xenograft rejection (DXR). We investigated the impact of warfarin or low-molecular-weight heparin (LMWH) anti-coagulation on xenograft function using a heterotopic pig-to-primate model. Donor hearts were from CD46 transgenic pigs and baboon immunosuppression included tacrolimus, sirolimus, anti-CD20 and TPC, an alpha-galactosyl-polyethylene glycol conjugate. Three groups of animals were studied. Group 1 (n = 9) was treated with warfarin, Group 2 (n = 13) with LMWH and Group 3, received no anti-coagulant drugs. The median duration of xenograft function was 20 days (range 3-62 days), 18 days (range 5-109 days) and 15 days (range 4-53 days) in Groups 1 to 3 respectively. Anti-coagulation achieved the targeted international normalized prothrombin ratio (INR) and anti-factor Xa levels consistent with effective in vivo therapy yet, no significant impact on median xenograft function was observed. At rejection, a similar histology of thrombosis and ischemia was apparent in each group and the levels of fibrin deposition and platelet thrombi in rejected tissue was the same. Anti-coagulation with warfarin or LMWH did not have a significant impact on the onset of DXR and microvascular thrombosis. However, a role for specific anti-coagulant strategies to achieve long-term xenograft function cannot be excluded.  相似文献   
73.
The purpose of this study was to provide, in a large number of patients, comprehensive Doppler echocardiographic assessment of normal St Jude Medical mitral valve prosthesis function using Doppler-derived hemodynamic variables, including the mitral valve prosthesis-to-left ventricular outflow tract time-velocity integral ratio and prosthesis performance index. The pressure half-time was less than 130 milliseconds in all patients, and all but one patient had either a peak early mitral diastolic velocity of 2 m/s or less or a mitral valve prosthesis-to-left ventricular outflow tract time-velocity integral ratio of less than 2.2. There was a significant (P < .001) negative correlation between the prosthesis performance index and prosthesis size. This negative correlation suggests that there is more efficient use of the in vitro geometric orifice area with smaller prostheses.  相似文献   
74.
OBJECTIVE: This study was designed to investigate potential areas of practice for the clinical laboratory scientist (CLS) and to propose a graduate curriculum to prepare the practitioner for an advanced level of practice. DESIGN: Meta-analysis of PharmD, physician assistant, physical therapy, and nurse practitioner curricula focusing on academic and clinical advanced practice was used to develop an educational model and curriculum for a professional doctorate in clinical laboratory science (CLS). MAIN OUTCOME MEASURE: (1) New educational model for CLS advanced practice; (2) A proposed curriculum for a Doctorate of Clinical Laboratory Science degree. RESULTS: A new curriculum model was adapted from established healthcare educational models. CONCLUSION: Although there is a need for a baccalaureate degree in CLS there is also a role for expanded education and responsibilities for CLS practitioners. The CLS Advanced Practitioner design focuses on moving students from the baccalaureate level to the doctoral level and prepares the individual to become an integral part of the healthcare team.  相似文献   
75.
76.
77.
Dental management of patients with autoimmune vesiculobullous disorders is complicated because of prominent involvement of oral mucosa, increased risk of oral disease, and difficulty in rendering dental care. Although these diseases are relatively uncommon, dental practitioners should be familiar with the oral sequelae of these conditions and their management. Pemphigus vulgaris, cicatricial pemphigoid, and epidermolysis bullosa represent the most common autoimmune oral vesiculobullous diseases. This case-illustrated review summarizes the pathogenesis, diagnostic features, and natural history of oral vesiculobullous disorders, placing an emphasis on the treatment and prevention of associated oral disease aimed at maintaining a healthy, functional dentition.  相似文献   
78.
79.
80.
Originally described by Rosen in 1983, syringomatous nipple adenoma (SAN) is a tumor of disputed histogenesis, which can be problematic both diagnostically and therapeutically. 1 It is a benign primary tumor of breast epithelium with histology similar to that of the syringoma. In the current case, we describe a 40-year-old female with this lesion occurring within a supernumerary breast. This case represents, to our knowledge, the first such reported case, and represents a significant finding as its presence could lend some confusion as to whether or not this represents a benign primary process of breast or a potentially infiltrative tumor of the skin.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号